Novartis Spinoff Sandoz to Start Trading as Standalone Drugmaker

Tainted Medication Fears Spur US Defense Department to Seek Outside Testing

Private Equity Firms Have $1.5 Trillion to Spend, But Are Struggling to Seal Deals